171 related articles for article (PubMed ID: 23591848)
1. Loss of SUMOylation on ATF3 inhibits proliferation of prostate cancer cells by modulating CCND1/2 activity.
Wang CM; Yang WH
Int J Mol Sci; 2013 Apr; 14(4):8367-80. PubMed ID: 23591848
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
3. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
Kim YC; Chen C; Bolton EC
PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
[TBL] [Abstract][Full Text] [Related]
4. The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor.
Wang H; Jiang M; Cui H; Chen M; Buttyan R; Hayward SW; Hai T; Wang Z; Yan C
Mol Cell Biol; 2012 Aug; 32(16):3190-202. PubMed ID: 22665497
[TBL] [Abstract][Full Text] [Related]
5. Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance.
Srivastava SK; Bhardwaj A; Singh S; Arora S; McClellan S; Grizzle WE; Reed E; Singh AP
Carcinogenesis; 2012 Jun; 33(6):1149-57. PubMed ID: 22431717
[TBL] [Abstract][Full Text] [Related]
6. SUMO-3 enhances androgen receptor transcriptional activity through a sumoylation-independent mechanism in prostate cancer cells.
Zheng Z; Cai C; Omwancha J; Chen SY; Baslan T; Shemshedini L
J Biol Chem; 2006 Feb; 281(7):4002-12. PubMed ID: 16361251
[TBL] [Abstract][Full Text] [Related]
7. The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer.
Pelzer AE; Bektic J; Haag P; Berger AP; Pycha A; Schäfer G; Rogatsch H; Horninger W; Bartsch G; Klocker H
J Urol; 2006 Apr; 175(4):1517-22. PubMed ID: 16516039
[TBL] [Abstract][Full Text] [Related]
8. Loss of mir-146a function in hormone-refractory prostate cancer.
Lin SL; Chiang A; Chang D; Ying SY
RNA; 2008 Mar; 14(3):417-24. PubMed ID: 18174313
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal.
Niknejad N; Gorn-Hondermann I; Ma L; Zahr S; Johnson-Obeseki S; Corsten M; Dimitroulakos J
Int J Cancer; 2014 Jan; 134(2):268-79. PubMed ID: 23824972
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
11. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
12. Pc2-mediated SUMOylation of WWOX is essential for its suppression of DU145 prostate tumorigenesis.
Choi HJ; Park JH; Park JH; Lee KB; Oh SM
FEBS Lett; 2015 Dec; 589(24 Pt B):3977-88. PubMed ID: 26592150
[TBL] [Abstract][Full Text] [Related]
13. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
[TBL] [Abstract][Full Text] [Related]
14. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
James CG; Woods A; Underhill TM; Beier F
BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628
[TBL] [Abstract][Full Text] [Related]
16. Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells.
Sen A; O'Malley K; Wang Z; Raj GV; Defranco DB; Hammes SR
J Biol Chem; 2010 Sep; 285(37):28787-95. PubMed ID: 20628053
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
18. Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells.
Wang Z; Kim J; Teng Y; Ding HF; Zhang J; Hai T; Cowell JK; Yan C
Oncogene; 2016 Jul; 35(27):3555-64. PubMed ID: 26522727
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of the twigs of Cinnamomum cassia through the suppression of cell proliferation and the induction of apoptosis in human colorectal cancer cells.
Park GH; Song HM; Park SB; Son HJ; Um Y; Kim HS; Jeong JB
BMC Complement Altern Med; 2018 Jan; 18(1):28. PubMed ID: 29554905
[TBL] [Abstract][Full Text] [Related]
20. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.
Bandyopadhyay S; Wang Y; Zhan R; Pai SK; Watabe M; Iiizumi M; Furuta E; Mohinta S; Liu W; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Hai T; Watabe K
Cancer Res; 2006 Dec; 66(24):11983-90. PubMed ID: 17178897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
